THERACLE Trademark

Trademark Overview


On Thursday, September 30, 2021, a trademark application was filed for THERACLE with the United States Patent and Trademark Office. The USPTO has given the THERACLE trademark a serial number of 97055312. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, September 10, 2024. This trademark is owned by Theracle, Inc.. The THERACLE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Implantable drug delivery devices sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug reservoir devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug refill devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies

Medical device in the form of an implant for medical diagnosis, treatment, or medication release sold empty, namely, implantable drug delivery devices; surgical implants comprised of artificial material; implantable drug delivery ports; drug reservoir devices sold empty used for administering drugs, namely, implantable drug reservoirs; drug refill devices sold empty used for administering drugs, namely, drug refillers
theracle

General Information


Serial Number97055312
Word MarkTHERACLE
Filing DateThursday, September 30, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements


Goods and ServicesImplantable drug delivery devices sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug reservoir devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies; drug refill devices used for administering drugs sold filled with pharmaceutical preparations for the treatment of brain cancer and brain maladies
Goods and ServicesMedical device in the form of an implant for medical diagnosis, treatment, or medication release sold empty, namely, implantable drug delivery devices; surgical implants comprised of artificial material; implantable drug delivery ports; drug reservoir devices sold empty used for administering drugs, namely, implantable drug reservoirs; drug refill devices sold empty used for administering drugs, namely, drug refillers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTheracle, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78249

Party NameTheracle, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78249

Trademark Events


Event DateEvent Description
Monday, October 4, 2021NEW APPLICATION ENTERED
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Thursday, June 30, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 23, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, August 11, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 21, 2023NON-FINAL ACTION WRITTEN
Monday, August 21, 2023NON-FINAL ACTION E-MAILED
Monday, August 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024SOU EXTENSION 1 FILED
Tuesday, September 10, 2024SOU EXTENSION 1 GRANTED